Antipsychotics: Typical and Atypical — MCQs
Sedation as an adverse effect is most commonly associated with which of the following atypical antipsychotics?
Antipsychotic drug with the least extrapyramidal symptoms?
A young patient with schizophrenia is resistant to treatment with conventional antipsychotic medications. Which drug is most preferred?
Which of the following is an atypical antipsychotic?
Which drug is commonly used to mitigate the side effects of haloperidol?
Which antipsychotic is most likely to cause metabolic syndrome?
What is the treatment for extrapyramidal side effects induced by Haloperidol?
The use of levodopa is avoided in which of the following patients?
Choose the correctly matched pairs regarding the drugs used in schizophrenia: 1. D2 antagonism: Reduces positive symptoms 2. 5HT2A antagonism: Reduces negative symptoms 3. 5HT1A agonism: Weight loss 4. Muscarinic antagonism: Reduces extrapyramidal symptoms
Which neuroleptic is most commonly associated with causing tardive dyskinesia?
Antipsychotics: Typical and Atypical Indian Medical PG Practice Questions and MCQs
Question 1: Sedation as an adverse effect is most commonly associated with which of the following atypical antipsychotics?
- A. Risperidone
- B. Olanzapine
- C. Quetiapine (Correct Answer)
- D. Aripiprazole
Explanation: ***Quetiapine*** - **Quetiapine** is known for its strong **H1 histamine receptor blockade**, which directly contributes to its prominent sedating effects. - This sedation is often dose-dependent and can be beneficial for patients with insomnia or agitation, but it is also a common complaint and reason for discontinuation. - Among the options listed, quetiapine is classically taught as the **most sedating** atypical antipsychotic. *Risperidone* - While risperidone can cause some sedation [1], it is generally less sedating than quetiapine or olanzapine and is more commonly associated with **extrapyramidal symptoms (EPS)**, especially at higher doses [1]. - Its mechanism of action primarily involves **D2 dopamine receptor blockade** and **5-HT2A serotonin receptor blockade** [1]. *Olanzapine* - **Olanzapine** also causes significant sedation [1] due to its strong antagonism of **H1 histamine receptors** and **alpha-1 adrenergic receptors**. - Clinically, olanzapine's sedative effects are comparable to quetiapine, though quetiapine is traditionally emphasized in exam contexts as the most sedating among these options. - Olanzapine is additionally notable for significant **metabolic side effects** like weight gain and dyslipidemia. *Aripiprazole* - **Aripiprazole** acts as a **partial agonist** at D2 dopamine receptors and 5-HT1A serotonin receptors, and an antagonist at 5-HT2A serotonin receptors, which results in minimal sedation. - It is often considered to be more **activating** or have a **neutral** effect on sedation compared to other atypical antipsychotics.
Question 2: Antipsychotic drug with the least extrapyramidal symptoms?
- A. Pimozide
- B. Clozapine (Correct Answer)
- C. Fluphenazine
- D. Thioridazine
Explanation: ***Clozapine***- **Atypical antipsychotics** like clozapine have a **lower affinity for D2 dopamine receptors** and a higher affinity for serotonin 5-HT2A receptors, which contributes to their reduced risk of EPS.- It is known for its effectiveness in **treatment-resistant schizophrenia** and its **low propensity for causing movement disorders** [1, 2].*Pimozide*- **Pimozide** is a **typical antipsychotic** (first-generation) that has a high affinity for D2 dopamine receptors.- This strong D2 antagonism leads to a **higher risk of extrapyramidal symptoms**.*Thioridazine*- **Thioridazine** is a **low-potency typical antipsychotic** that, while having a lower incidence of EPS compared to high-potency typicals, still carries a significant risk [1].- It is associated with other side effects such as **cardiac conduction abnormalities** (e.g., QT prolongation) at higher doses.*Fluphenazine*- **Fluphenazine** is a **high-potency typical antipsychotic** with strong D2 receptor antagonism.- High-potency typical antipsychotics like **Fluphenazine** are known for their **high risk of extrapyramidal symptoms** [1].
Question 3: A young patient with schizophrenia is resistant to treatment with conventional antipsychotic medications. Which drug is most preferred?
- A. Haloperidol
- B. Olanzapine
- C. Clozapine (Correct Answer)
- D. Risperidone
Explanation: ***Clozapine*** - **Clozapine** is the drug of choice for **treatment-resistant schizophrenia** or patients who are **intolerant to conventional antipsychotics**. - Its unique efficacy often comes with a risk of **agranulocytosis**, requiring regular **blood monitoring**. *Olanzapine* - While an effective **atypical antipsychotic**, it is not specifically indicated for **treatment-resistant cases** in the same way as clozapine. - It carries a risk of significant **metabolic side effects**, such as weight gain and dyslipidemia. *Haloperidol* - This is a **first-generation (conventional) antipsychotic** and would be unsuitable for a patient described as **intolerant to conventional antipsychotics**. - It is associated with a high incidence of **extrapyramidal symptoms (EPS)** and **tardive dyskinesia**. *Risperidone* - As an **atypical antipsychotic**, it is a good first-line option but is not typically reserved for **treatment-resistant schizophrenia** or those with conventional antipsychotic intolerance. - It has a higher propensity for **hyperprolactinemia** compared to other atypical antipsychotics.
Question 4: Which of the following is an atypical antipsychotic?
- A. Clozapine (Correct Answer)
- B. Chlorpromazine
- C. Thiothixene
- D. Haloperidol
Explanation: ***Clozapine*** - **Clozapine** is an **atypical antipsychotic** characterized by its efficacy in treating **refractory schizophrenia** and a lower risk of **extrapyramidal symptoms (EPS)** compared to typical antipsychotics. - Its mechanism involves antagonism of **dopamine D2** and **serotonin 5-HT2A** receptors, as well as several other receptor types. *Chlorpromazine* - **Chlorpromazine** is a **typical (first-generation) antipsychotic**, known for its strong **D2 blockade** and higher incidence of **extrapyramidal side effects**. - It was one of the first antipsychotics developed and is also used for its **antiemetic** properties. *Thiothixene* - **Thiothixene** is a **typical (first-generation) antipsychotic** that primarily acts by blocking **dopamine D2 receptors**. - It is associated with a higher risk of **extrapyramidal symptoms** and other side effects characteristic of typical antipsychotics. *Haloperidol* - **Haloperidol** is a **high-potency typical (first-generation) antipsychotic** with potent **D2 receptor antagonism**. - It is often used for acute psychosis and delirium but carries a significant risk of **extrapyramidal side effects** and **tardive dyskinesia**.
Question 5: Which drug is commonly used to mitigate the side effects of haloperidol?
- A. Clozapine
- B. Imipramine
- C. Benztropine (Correct Answer)
- D. Haloperidol
Explanation: ***Correct Option C: Benztropine*** - **Benztropine** is an **anticholinergic medication** commonly used to treat **extrapyramidal symptoms (EPS)** induced by antipsychotics like haloperidol - EPS, such as **dystonia**, **akathisia**, and **parkinsonism**, occur due to dopaminergic blockade in the nigrostriatal pathway - Benztropine works by blocking muscarinic receptors, helping to restore the dopamine-acetylcholine balance in the basal ganglia *Incorrect Option A: Clozapine* - **Clozapine** is an **atypical antipsychotic** known for its effectiveness in **treatment-resistant schizophrenia** and a lower risk of EPS compared to typical antipsychotics - However, it is not used to mitigate existing side effects of other antipsychotics due to its unique side effect profile, including agranulocytosis and myocarditis - Clozapine is a therapeutic alternative, not a treatment for EPS *Incorrect Option B: Imipramine* - **Imipramine** is a **tricyclic antidepressant (TCA)** primarily used to treat **depression** and **anxiety disorders** - It does not have properties that would mitigate the extrapyramidal side effects induced by antipsychotics - TCAs have anticholinergic properties but are not used for EPS management *Incorrect Option D: Haloperidol* - **Haloperidol** is a **typical antipsychotic** itself, and it is the drug whose side effects (e.g., EPS) are being mitigated - Administering more haloperidol would exacerbate, not mitigate, its side effects - This is the causative agent, not the treatment
Question 6: Which antipsychotic is most likely to cause metabolic syndrome?
- A. Olanzapine
- B. Haloperidol
- C. Clozapine (Correct Answer)
- D. Risperidone
Explanation: ***Clozapine*** - **Clozapine** has the **highest risk** of causing **metabolic syndrome** among all antipsychotics, characterized by significant **weight gain**, **dyslipidemia**, **insulin resistance**, and **new-onset diabetes mellitus**. - Multiple meta-analyses consistently show clozapine causes the **most severe metabolic disturbances**, with weight gain often exceeding 5-10 kg in the first year of treatment. - The mechanism involves potent antagonism of **5-HT2C receptors**, **histamine H1 receptors**, and effects on **leptin signaling** and **glucose metabolism**. - Its use requires careful **metabolic monitoring** including baseline and periodic measurement of weight, BMI, waist circumference, fasting glucose, and lipid profile. - Despite these risks, clozapine remains the gold standard for **treatment-resistant schizophrenia**, but its metabolic effects necessitate risk-benefit consideration. *Olanzapine* - **Olanzapine** has the **second-highest risk** for metabolic syndrome after clozapine, also causing significant weight gain and metabolic disturbances. - Like clozapine, it has potent **5-HT2C** and **H1 antagonism**, leading to increased appetite and altered glucose-lipid metabolism. - The metabolic risk is substantial but generally slightly less severe than clozapine in head-to-head comparisons. *Haloperidol* - **Haloperidol** is a first-generation (typical) antipsychotic with a **significantly lower risk** of metabolic syndrome compared to clozapine or olanzapine. - Its primary adverse effects are **extrapyramidal symptoms** (akathisia, dystonia, parkinsonism) and **hyperprolactinemia** rather than metabolic disturbances. - It causes minimal weight gain and has low risk for diabetes or dyslipidemia. *Risperidone* - **Risperidone** has an **intermediate metabolic risk** among atypical antipsychotics, lower than clozapine or olanzapine but higher than some others like aripiprazole or ziprasidone. - While it can cause weight gain and metabolic changes, the magnitude is generally more modest. - Its more prominent side effect is **hyperprolactinemia** due to potent D2 antagonism.
Question 7: What is the treatment for extrapyramidal side effects induced by Haloperidol?
- A. Barbiturates
- B. SSRIs
- C. Benzodiazepines
- D. Anticholinergic drugs (Correct Answer)
Explanation: ***Anticholinergic drugs (effective treatment)*** - **Anticholinergic medications**, such as **benztropine** or **diphenhydramine**, are the primary treatment for **acute extrapyramidal symptoms (EPS)** like dystonia and parkinsonism induced by antipsychotics like haloperidol. - They work by **blocking muscarinic acetylcholine receptors**, helping to restore the balance between dopamine and acetylcholine in the basal ganglia. *Benzodiazepines (used for anxiety and muscle relaxation)* - While benzodiazepines can offer some relief for **akathisia** (a form of EPS characterized by restlessness) due to their sedative and muscle relaxant properties, they are **not the first-line treatment for other acute EPS** such as dystonia or parkinsonism. - They primarily enhance **GABAergic transmission** and are effective for anxiety and seizure control rather than direct antagonism of EPS mechanisms. *Barbiturates (used as sedative-hypnotic drugs)* - **Barbiturates** are strong central nervous system depressants used for sedation, anesthesia, and seizure control, but are **not indicated for the treatment of EPS**. - Their significant **sedative and addictive potential**, along with a narrow therapeutic index, makes them unsuitable for this purpose. *SSRIs (used for depression and anxiety)* - **SSRIs (Selective Serotonin Reuptake Inhibitors)** are antidepressants that work by increasing serotonin levels in the brain and are used to treat depression, anxiety, and obsessive-compulsive disorder. - They **do not have a direct role** in ameliorating dopamine-acetylcholine imbalance responsible for haloperidol-induced EPS.
Question 8: The use of levodopa is avoided in which of the following patients?
- A. Amyotrophic lateral sclerosis
- B. Psychosis (Correct Answer)
- C. Alzheimer's disease
- D. Essential tremor
Explanation: ***Psychosis*** - Levodopa increases **dopaminergic activity** in the brain, which can significantly worsen or induce **psychotic symptoms** like hallucinations and delusions. - Patients with pre-existing psychosis or a history of psychotic episodes are at high risk, making levodopa a **contraindicated** treatment. *Alzheimer's disease* - While Alzheimer's patients may experience motor symptoms, levodopa is generally not avoided unless there are specific **parkinsonian features** responsive to dopamine. - The primary symptoms of Alzheimer's are **cognitive decline**, which levodopa does not treat and could potentially worsen agitation or confusion in advanced stages. *Amyotrophic lateral sclerosis* - **ALS** is a progressive neurodegenerative disease affecting motor neurons, leading to muscle weakness and atrophy. - Levodopa is **not effective** in treating ALS because the disease pathology does not involve dopamine deficiency. *Essential tremor* - Essential tremor is a movement disorder primarily treated with **beta-blockers** or **anti-seizure medications**. - Levodopa has **no established efficacy** in treating essential tremor, and its use is unrelated to its pathophysiology.
Question 9: Choose the correctly matched pairs regarding the drugs used in schizophrenia: 1. D2 antagonism: Reduces positive symptoms 2. 5HT2A antagonism: Reduces negative symptoms 3. 5HT1A agonism: Weight loss 4. Muscarinic antagonism: Reduces extrapyramidal symptoms
- A. 1,4
- B. 1,2,4
- C. 1,2,3,4
- D. 1,2 (Correct Answer)
Explanation: ***1,2*** - **D2 antagonism** is the primary mechanism by which antipsychotics reduce **positive symptoms** of schizophrenia, such as hallucinations and delusions. - **5HT2A antagonism** is a key mechanism of atypical antipsychotics contributing to the reduction of **negative symptoms** (e.g., apathy, anhedonia, flat affect) and cognitive deficits, while also reducing the risk of extrapyramidal symptoms. *1,2,3,4* - This option is incorrect because **5HT1A agonism** is not associated with **weight loss**. While 5HT1A partial agonism (as seen with aripiprazole and brexpiprazole) may improve negative symptoms, anxiety, and cognitive function, it does not directly cause weight loss. - Additionally, **muscarinic antagonism** does not reduce extrapyramidal symptoms as a primary mechanism. Rather, anticholinergic (muscarinic antagonist) drugs like benztropine are used to **treat** EPS after it occurs. The reduction of EPS in atypical antipsychotics primarily comes from 5HT2A antagonism and lower D2 binding affinity. *1,2,4* - This option is incorrect because **muscarinic antagonism** is not a mechanism that reduces EPS. Anticholinergic agents are used therapeutically to counteract EPS caused by dopamine blockade, but anticholinergic effects themselves do not prevent or reduce EPS. - The reduction of EPS with atypical antipsychotics is mainly due to **5HT2A antagonism** balancing dopaminergic blockade, selective limbic over striatal binding, and fast D2 dissociation kinetics. *1,4* - This option is incorrect because it omits **5HT2A antagonism**, which is crucial for reducing **negative symptoms** in schizophrenia. - It also incorrectly includes muscarinic antagonism as a mechanism that reduces EPS, when in reality anticholinergics are used to treat EPS rather than prevent it.
Question 10: Which neuroleptic is most commonly associated with causing tardive dyskinesia?
- A. Olanzapine
- B. Haloperidol (Correct Answer)
- C. Clozapine
- D. Risperidone
Explanation: ***Haloperidol*** - **Haloperidol** is a **first-generation (typical) antipsychotic** that acts as a strong **dopamine D2 receptor antagonist**. This potent blockade increases the risk of **extrapyramidal symptoms (EPS)**, including tardive dyskinesia, especially with long-term use. - **Tardive dyskinesia (TD)** is characterized by involuntary, repetitive movements, particularly of the face, mouth, and tongue. Its development is strongly linked to the duration and dosage of typical antipsychotics like haloperidol. *Clozapine* - **Clozapine** is a **second-generation (atypical) antipsychotic** known for its very low risk of causing **tardive dyskinesia** and other **extrapyramidal symptoms**. - Its mechanism involves both dopamine and serotonin receptor antagonism, with a weaker, more transient D2 blockade. *Olanzapine* - **Olanzapine** is also a **second-generation (atypical) antipsychotic** with a relatively low risk of causing **tardive dyskinesia** compared to first-generation agents. - While it can cause EPS, its incidence is significantly lower than that of typical antipsychotics. *Risperidone* - **Risperidone** is an **atypical antipsychotic** that, at higher doses, can have a **stronger D2 receptor blockade** compared to other atypicals, making its risk of **extrapyramidal symptoms** (including tardive dyskinesia) somewhat higher than other second-generation agents, though still lower than typical antipsychotics. - Its D2 antagonism is more pronounced than drugs like clozapine or quetiapine.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free